Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Novel molecular targeted therapies for refractory thyroid cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel molecular targeted therapies for refractory thyroid cancer.
Novel molecular targeted therapies for refractory thyroid cancer. Head Neck. 2012 May; 34(5):736-45.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Anilides
Antineoplastic Agents
Benzamides
Benzenesulfonates
Benzoquinones
Bibenzyls
Boronic Acids
Bortezomib
Depsipeptides
ErbB Receptors
Histone Deacetylase Inhibitors
HSP90 Heat-Shock Proteins
Humans
Hydroxamic Acids
Imatinib Mesylate
Imidazoles
Indazoles
Indoles
Lactams, Macrocyclic
Niacinamide
Oligonucleotides
Phenylurea Compounds
Piperazines
Piperidines
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-kit
Pyrazines
Pyridines
Pyrimidines
Pyrroles
Quinazolines
Quinolines
Receptor Protein-Tyrosine Kinases
Receptors, Vascular Endothelial Growth Factor
Sulfonamides
Thalidomide
Thyroid Neoplasms
Valproic Acid
authors with profiles
Ezra Cohen